Verisante Technology Inc.
Verisante Technology Inc. VRSEF Peers
See (VRSEF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VRSEF | $0.00 | N/A | 316.8K | 0.03 | $0.07 | N/A |
| SEMHF | $55.30 | N/A | 62B | 26.21 | $2.11 | +2.04% |
| SMMNY | $26.35 | -3.23% | 59.1B | 25.10 | $1.05 | +1.28% |
| RYLPF | $23.30 | N/A | 21.6B | 80.34 | $0.29 | +4.05% |
| SONVF | $323.26 | N/A | 19.3B | 29.49 | $10.96 | +1.81% |
| SONVY | $64.22 | +0.17% | 19.1B | 29.32 | $2.19 | +1.48% |
| SNNUF | $14.21 | N/A | 12.4B | 30.23 | $0.47 | +2.64% |
| CHEOY | $86.38 | -0.08% | 11.3B | 47.72 | $1.81 | +1.62% |
| CHEOF | $167.01 | N/A | 10.9B | 45.88 | $3.64 | +1.66% |
| WILYY | $20.20 | N/A | 8.6B | 20.00 | $1.01 | N/A |
Stock Comparison
VRSEF vs SEMHF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SEMHF has a market cap of 62B. Regarding current trading prices, VRSEF is priced at $0.00, while SEMHF trades at $55.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SEMHF's P/E ratio is 26.21. In terms of profitability, VRSEF's ROE is +3.92%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, VRSEF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs SMMNY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SMMNY has a market cap of 59.1B. Regarding current trading prices, VRSEF is priced at $0.00, while SMMNY trades at $26.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SMMNY's P/E ratio is 25.10. In terms of profitability, VRSEF's ROE is +3.92%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, VRSEF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs RYLPF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, RYLPF has a market cap of 21.6B. Regarding current trading prices, VRSEF is priced at $0.00, while RYLPF trades at $23.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas RYLPF's P/E ratio is 80.34. In terms of profitability, VRSEF's ROE is +3.92%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, VRSEF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs SONVF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SONVF has a market cap of 19.3B. Regarding current trading prices, VRSEF is priced at $0.00, while SONVF trades at $323.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SONVF's P/E ratio is 29.49. In terms of profitability, VRSEF's ROE is +3.92%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, VRSEF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs SONVY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SONVY has a market cap of 19.1B. Regarding current trading prices, VRSEF is priced at $0.00, while SONVY trades at $64.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SONVY's P/E ratio is 29.32. In terms of profitability, VRSEF's ROE is +3.92%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, VRSEF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs SNNUF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SNNUF has a market cap of 12.4B. Regarding current trading prices, VRSEF is priced at $0.00, while SNNUF trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SNNUF's P/E ratio is 30.23. In terms of profitability, VRSEF's ROE is +3.92%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, VRSEF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CHEOY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CHEOY has a market cap of 11.3B. Regarding current trading prices, VRSEF is priced at $0.00, while CHEOY trades at $86.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CHEOY's P/E ratio is 47.72. In terms of profitability, VRSEF's ROE is +3.92%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, VRSEF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CHEOF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CHEOF has a market cap of 10.9B. Regarding current trading prices, VRSEF is priced at $0.00, while CHEOF trades at $167.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CHEOF's P/E ratio is 45.88. In terms of profitability, VRSEF's ROE is +3.92%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, VRSEF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs WILYY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, WILYY has a market cap of 8.6B. Regarding current trading prices, VRSEF is priced at $0.00, while WILYY trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas WILYY's P/E ratio is 20.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, VRSEF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs WILLF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, WILLF has a market cap of 7.9B. Regarding current trading prices, VRSEF is priced at $0.00, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas WILLF's P/E ratio is 18.93. In terms of profitability, VRSEF's ROE is +3.92%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, VRSEF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs GNGBF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, GNGBF has a market cap of 5.4B. Regarding current trading prices, VRSEF is priced at $0.00, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas GNGBF's P/E ratio is 37.04. In terms of profitability, VRSEF's ROE is +3.92%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, VRSEF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs GNGBY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, GNGBY has a market cap of 5.2B. Regarding current trading prices, VRSEF is priced at $0.00, while GNGBY trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas GNGBY's P/E ratio is 34.20. In terms of profitability, VRSEF's ROE is +3.92%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, VRSEF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs AMBBY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, AMBBY has a market cap of 4.1B. Regarding current trading prices, VRSEF is priced at $0.00, while AMBBY trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas AMBBY's P/E ratio is 73.10. In terms of profitability, VRSEF's ROE is +3.92%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, VRSEF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs AMBFF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, AMBFF has a market cap of 4B. Regarding current trading prices, VRSEF is priced at $0.00, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, VRSEF's ROE is +3.92%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, VRSEF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs NHNKY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, NHNKY has a market cap of 3.8B. Regarding current trading prices, VRSEF is priced at $0.00, while NHNKY trades at $11.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas NHNKY's P/E ratio is 19.26. In terms of profitability, VRSEF's ROE is +3.92%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, VRSEF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs NHNKF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, VRSEF is priced at $0.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, VRSEF's ROE is +3.92%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, VRSEF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs VTRLY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, VTRLY has a market cap of 2.2B. Regarding current trading prices, VRSEF is priced at $0.00, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, VRSEF's ROE is +3.92%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, VRSEF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs STSEY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, VRSEF is priced at $0.00, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas STSEY's P/E ratio is 39.41. In terms of profitability, VRSEF's ROE is +3.92%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, VRSEF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs GNNDY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, GNNDY has a market cap of 2B. Regarding current trading prices, VRSEF is priced at $0.00, while GNNDY trades at $40.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas GNNDY's P/E ratio is 16.20. In terms of profitability, VRSEF's ROE is +3.92%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, VRSEF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs GGNDF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, GGNDF has a market cap of 1.9B. Regarding current trading prices, VRSEF is priced at $0.00, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas GGNDF's P/E ratio is 15.48. In terms of profitability, VRSEF's ROE is +3.92%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, VRSEF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs OSSFF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, VRSEF is priced at $0.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, VRSEF's ROE is +3.92%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, VRSEF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs DWRKF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, VRSEF is priced at $0.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, VRSEF's ROE is +3.92%, compared to DWRKF's ROE of N/A. Regarding short-term risk, VRSEF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs MCRPF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, MCRPF has a market cap of 1.7B. Regarding current trading prices, VRSEF is priced at $0.00, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, VRSEF's ROE is +3.92%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, VRSEF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs SSII Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SSII has a market cap of 1.7B. Regarding current trading prices, VRSEF is priced at $0.00, while SSII trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SSII's P/E ratio is -110.25. In terms of profitability, VRSEF's ROE is +3.92%, compared to SSII's ROE of -1.33%. Regarding short-term risk, VRSEF is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs OSSUY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, VRSEF is priced at $0.00, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, VRSEF's ROE is +3.92%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, VRSEF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs MEDGF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, VRSEF is priced at $0.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, VRSEF's ROE is +3.92%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, VRSEF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs DRWKF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, DRWKF has a market cap of 1.2B. Regarding current trading prices, VRSEF is priced at $0.00, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas DRWKF's P/E ratio is 8.98. In terms of profitability, VRSEF's ROE is +3.92%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, VRSEF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs DGWPF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, VRSEF is priced at $0.00, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas DGWPF's P/E ratio is 7.61. In terms of profitability, VRSEF's ROE is +3.92%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, VRSEF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs XVIPF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, XVIPF has a market cap of 1B. Regarding current trading prices, VRSEF is priced at $0.00, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, VRSEF's ROE is +3.92%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, VRSEF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs LFTSF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, VRSEF is priced at $0.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, VRSEF's ROE is +3.92%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, VRSEF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs ELEAF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, ELEAF has a market cap of 832.5M. Regarding current trading prices, VRSEF is priced at $0.00, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas ELEAF's P/E ratio is 12.08. In terms of profitability, VRSEF's ROE is +3.92%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, VRSEF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs MDRSF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, MDRSF has a market cap of 826.6M. Regarding current trading prices, VRSEF is priced at $0.00, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, VRSEF's ROE is +3.92%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, VRSEF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CALZF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CALZF has a market cap of 586.5M. Regarding current trading prices, VRSEF is priced at $0.00, while CALZF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CALZF's P/E ratio is 84.90. In terms of profitability, VRSEF's ROE is +3.92%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, VRSEF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs AVMR Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, VRSEF is priced at $0.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas AVMR's P/E ratio is -18.34. In terms of profitability, VRSEF's ROE is +3.92%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, VRSEF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CLVSF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, VRSEF is priced at $0.00, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, VRSEF's ROE is +3.92%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, VRSEF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs IOBCF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, IOBCF has a market cap of 380.8M. Regarding current trading prices, VRSEF is priced at $0.00, while IOBCF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas IOBCF's P/E ratio is 37.14. In terms of profitability, VRSEF's ROE is +3.92%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, VRSEF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs HYBT Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, VRSEF is priced at $0.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas HYBT's P/E ratio is N/A. In terms of profitability, VRSEF's ROE is +3.92%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, VRSEF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs EAPIF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, EAPIF has a market cap of 290.4M. Regarding current trading prices, VRSEF is priced at $0.00, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas EAPIF's P/E ratio is -1.98. In terms of profitability, VRSEF's ROE is +3.92%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, VRSEF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CSSPF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CSSPF has a market cap of 263.4M. Regarding current trading prices, VRSEF is priced at $0.00, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, VRSEF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CLLKF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CLLKF has a market cap of 253.2M. Regarding current trading prices, VRSEF is priced at $0.00, while CLLKF trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CLLKF's P/E ratio is -8.14. In terms of profitability, VRSEF's ROE is +3.92%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, VRSEF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CYBQY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CYBQY has a market cap of 249.5M. Regarding current trading prices, VRSEF is priced at $0.00, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CYBQY's P/E ratio is -61.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, VRSEF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs HTLZF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, VRSEF is priced at $0.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, VRSEF's ROE is +3.92%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, VRSEF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs SNWV Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SNWV has a market cap of 244.3M. Regarding current trading prices, VRSEF is priced at $0.00, while SNWV trades at $28.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SNWV's P/E ratio is -4.58. In terms of profitability, VRSEF's ROE is +3.92%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, VRSEF is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs BCCOY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, VRSEF is priced at $0.00, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, VRSEF's ROE is +3.92%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, VRSEF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs IMPZY Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, VRSEF is priced at $0.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, VRSEF's ROE is +3.92%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, VRSEF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CYBQF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CYBQF has a market cap of 173.5M. Regarding current trading prices, VRSEF is priced at $0.00, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, VRSEF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs AVHHL Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, AVHHL has a market cap of 166M. Regarding current trading prices, VRSEF is priced at $0.00, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, VRSEF's ROE is +3.92%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, VRSEF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs BRNHF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, BRNHF has a market cap of 161.8M. Regarding current trading prices, VRSEF is priced at $0.00, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, VRSEF's ROE is +3.92%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, VRSEF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs EKDHF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, EKDHF has a market cap of 161.7M. Regarding current trading prices, VRSEF is priced at $0.00, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, VRSEF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs JMDMF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, JMDMF has a market cap of 152M. Regarding current trading prices, VRSEF is priced at $0.00, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, VRSEF's ROE is +3.92%, compared to JMDMF's ROE of N/A. Regarding short-term risk, VRSEF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs PXMBF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, PXMBF has a market cap of 139.7M. Regarding current trading prices, VRSEF is priced at $0.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, VRSEF's ROE is +3.92%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, VRSEF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs BRSYF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, BRSYF has a market cap of 128.4M. Regarding current trading prices, VRSEF is priced at $0.00, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, VRSEF's ROE is +3.92%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, VRSEF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs AMEUF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, VRSEF is priced at $0.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, VRSEF's ROE is +3.92%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, VRSEF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs VMTHF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, VRSEF is priced at $0.00, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, VRSEF's ROE is +3.92%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, VRSEF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs FDMDF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, FDMDF has a market cap of 102.7M. Regarding current trading prices, VRSEF is priced at $0.00, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, VRSEF's ROE is +3.92%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, VRSEF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs RSHUF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, VRSEF is priced at $0.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, VRSEF's ROE is +3.92%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, VRSEF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs CKMTF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, VRSEF is priced at $0.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, VRSEF's ROE is +3.92%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, VRSEF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs SOMNF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SOMNF has a market cap of 84.3M. Regarding current trading prices, VRSEF is priced at $0.00, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, VRSEF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs DMTRF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, DMTRF has a market cap of 76.1M. Regarding current trading prices, VRSEF is priced at $0.00, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, VRSEF's ROE is +3.92%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, VRSEF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs SNZZF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, SNZZF has a market cap of 71.9M. Regarding current trading prices, VRSEF is priced at $0.00, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas SNZZF's P/E ratio is -4.91. In terms of profitability, VRSEF's ROE is +3.92%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, VRSEF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs RDGL Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, RDGL has a market cap of 60.3M. Regarding current trading prices, VRSEF is priced at $0.00, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas RDGL's P/E ratio is -13.30. In terms of profitability, VRSEF's ROE is +3.92%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, VRSEF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs BLOZF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, BLOZF has a market cap of 49.3M. Regarding current trading prices, VRSEF is priced at $0.00, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas BLOZF's P/E ratio is -21.40. In terms of profitability, VRSEF's ROE is +3.92%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, VRSEF is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs IPDQF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, IPDQF has a market cap of 43M. Regarding current trading prices, VRSEF is priced at $0.00, while IPDQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas IPDQF's P/E ratio is -2.12. In terms of profitability, VRSEF's ROE is +3.92%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, VRSEF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs NVYTF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, NVYTF has a market cap of 38M. Regarding current trading prices, VRSEF is priced at $0.00, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas NVYTF's P/E ratio is -0.73. In terms of profitability, VRSEF's ROE is +3.92%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, VRSEF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs TLTFF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, TLTFF has a market cap of 29.7M. Regarding current trading prices, VRSEF is priced at $0.00, while TLTFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas TLTFF's P/E ratio is -12.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, VRSEF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs ELXMF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, VRSEF is priced at $0.00, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, VRSEF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs PYNKF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, PYNKF has a market cap of 26.2M. Regarding current trading prices, VRSEF is priced at $0.00, while PYNKF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas PYNKF's P/E ratio is -1.33. In terms of profitability, VRSEF's ROE is +3.92%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, VRSEF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs KBBTF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, VRSEF is priced at $0.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, VRSEF's ROE is +3.92%, compared to KBBTF's ROE of N/A. Regarding short-term risk, VRSEF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs POSC Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, POSC has a market cap of 22.6M. Regarding current trading prices, VRSEF is priced at $0.00, while POSC trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas POSC's P/E ratio is 0.37. In terms of profitability, VRSEF's ROE is +3.92%, compared to POSC's ROE of +9.25%. Regarding short-term risk, VRSEF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs EMITF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, EMITF has a market cap of 22.2M. Regarding current trading prices, VRSEF is priced at $0.00, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas EMITF's P/E ratio is -14.29. In terms of profitability, VRSEF's ROE is +3.92%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, VRSEF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs ASAPF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, ASAPF has a market cap of 17.6M. Regarding current trading prices, VRSEF is priced at $0.00, while ASAPF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas ASAPF's P/E ratio is -22.50. In terms of profitability, VRSEF's ROE is +3.92%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, VRSEF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs DIZTF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, DIZTF has a market cap of 16.9M. Regarding current trading prices, VRSEF is priced at $0.00, while DIZTF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas DIZTF's P/E ratio is -7.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, VRSEF is more volatile compared to DIZTF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs MDXHF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, MDXHF has a market cap of 15.5M. Regarding current trading prices, VRSEF is priced at $0.00, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, VRSEF's ROE is +3.92%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, VRSEF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs VPTDF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, VPTDF has a market cap of 15M. Regarding current trading prices, VRSEF is priced at $0.00, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas VPTDF's P/E ratio is -4.59. In terms of profitability, VRSEF's ROE is +3.92%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, VRSEF is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs TMDIF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, VRSEF is priced at $0.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, VRSEF's ROE is +3.92%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, VRSEF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs PLLWF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, VRSEF is priced at $0.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, VRSEF's ROE is +3.92%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, VRSEF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs IMEXF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, IMEXF has a market cap of 11.7M. Regarding current trading prices, VRSEF is priced at $0.00, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas IMEXF's P/E ratio is N/A. In terms of profitability, VRSEF's ROE is +3.92%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, VRSEF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs ATBPF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, VRSEF is priced at $0.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, VRSEF's ROE is +3.92%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, VRSEF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs LXXGF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, VRSEF is priced at $0.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, VRSEF's ROE is +3.92%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, VRSEF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs GTHP Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, GTHP has a market cap of 11M. Regarding current trading prices, VRSEF is priced at $0.00, while GTHP trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas GTHP's P/E ratio is -2.80. In terms of profitability, VRSEF's ROE is +3.92%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, VRSEF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs RMSL Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, RMSL has a market cap of 10.7M. Regarding current trading prices, VRSEF is priced at $0.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas RMSL's P/E ratio is 0.70. In terms of profitability, VRSEF's ROE is +3.92%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, VRSEF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs NGMDF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, NGMDF has a market cap of 9.9M. Regarding current trading prices, VRSEF is priced at $0.00, while NGMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas NGMDF's P/E ratio is -0.01. In terms of profitability, VRSEF's ROE is +3.92%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, VRSEF is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs IRME Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, IRME has a market cap of 8.6M. Regarding current trading prices, VRSEF is priced at $0.00, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas IRME's P/E ratio is -4.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to IRME's ROE of +11.77%. Regarding short-term risk, VRSEF is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs ALRTF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, ALRTF has a market cap of 6.4M. Regarding current trading prices, VRSEF is priced at $0.00, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas ALRTF's P/E ratio is -0.33. In terms of profitability, VRSEF's ROE is +3.92%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, VRSEF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs TBRIF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, TBRIF has a market cap of 5.9M. Regarding current trading prices, VRSEF is priced at $0.00, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas TBRIF's P/E ratio is -1.30. In terms of profitability, VRSEF's ROE is +3.92%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, VRSEF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs MKEAF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, MKEAF has a market cap of 5.9M. Regarding current trading prices, VRSEF is priced at $0.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, VRSEF's ROE is +3.92%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, VRSEF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs DTXMF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, DTXMF has a market cap of 5.7M. Regarding current trading prices, VRSEF is priced at $0.00, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, VRSEF's ROE is +3.92%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, VRSEF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs QLIS Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, VRSEF is priced at $0.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas QLIS's P/E ratio is 2.22. In terms of profitability, VRSEF's ROE is +3.92%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, VRSEF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs RHNMF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, VRSEF is priced at $0.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, VRSEF's ROE is +3.92%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, VRSEF is more volatile compared to RHNMF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs MICR Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, MICR has a market cap of 4.7M. Regarding current trading prices, VRSEF is priced at $0.00, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas MICR's P/E ratio is -3.47. In terms of profitability, VRSEF's ROE is +3.92%, compared to MICR's ROE of -0.25%. Regarding short-term risk, VRSEF is more volatile compared to MICR. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs FZMD Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, FZMD has a market cap of 4.4M. Regarding current trading prices, VRSEF is priced at $0.00, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas FZMD's P/E ratio is 1.20. In terms of profitability, VRSEF's ROE is +3.92%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, VRSEF is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs NUMD Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, NUMD has a market cap of 4.3M. Regarding current trading prices, VRSEF is priced at $0.00, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas NUMD's P/E ratio is 5.20. In terms of profitability, VRSEF's ROE is +3.92%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, VRSEF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs LBLTF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, VRSEF is priced at $0.00, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, VRSEF's ROE is +3.92%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, VRSEF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs PMEDF Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, PMEDF has a market cap of 4.1M. Regarding current trading prices, VRSEF is priced at $0.00, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas PMEDF's P/E ratio is -2.70. In terms of profitability, VRSEF's ROE is +3.92%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, VRSEF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs ADMT Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, ADMT has a market cap of 4.1M. Regarding current trading prices, VRSEF is priced at $0.00, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas ADMT's P/E ratio is -6.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, VRSEF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs VYCO Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, VYCO has a market cap of 4M. Regarding current trading prices, VRSEF is priced at $0.00, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas VYCO's P/E ratio is -12.00. In terms of profitability, VRSEF's ROE is +3.92%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, VRSEF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs BIEL Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, BIEL has a market cap of 3.6M. Regarding current trading prices, VRSEF is priced at $0.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas BIEL's P/E ratio is N/A. In terms of profitability, VRSEF's ROE is +3.92%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, VRSEF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs VANIW Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, VRSEF is priced at $0.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas VANIW's P/E ratio is N/A. In terms of profitability, VRSEF's ROE is +3.92%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, VRSEF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for VRSEF.
VRSEF vs USAQ Comparison
VRSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VRSEF stands at 316.8K. In comparison, USAQ has a market cap of 2.9M. Regarding current trading prices, VRSEF is priced at $0.00, while USAQ trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VRSEF currently has a P/E ratio of 0.03, whereas USAQ's P/E ratio is -6.37. In terms of profitability, VRSEF's ROE is +3.92%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, VRSEF is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for VRSEF.